Medical Weight Loss Clinic in Tampa Bay
Program Supervised by Licensed Physician

Medical weight loss is a clinically supervised approach to weight management. It may combine a health evaluation, personalized nutrition and activity guidance, ongoing monitoring and prescription treatment when medically appropriate.

Unlike a generic diet plan, medical weight loss considers factors such as health history, medications, weight-related conditions, sleep, stress and previous weight-management efforts.

Medical weight loss includes evaluation and monitoring by qualified healthcare professionals. A regular commercial diet program may provide general meal or exercise guidance without assessing medical conditions, medication interactions or treatment eligibility.

A medical program can be adjusted over time according to your progress, side effects, health changes and individual response.

Eligibility depends on your body mass index, health history, weight-related conditions, current medications and treatment goals. Some prescription weight-management medications are approved for adults with obesity or for adults with overweight who also have at least one qualifying weight-related condition.

BMI alone does not determine whether a particular treatment is safe or appropriate. A medical provider must complete an individualized evaluation. NIDDK guidance on prescription weight-management medications

Your first consultation typically includes a review of your weight history, health conditions, medications, previous weight-loss attempts, eating patterns, activity, sleep and personal goals.

The provider may also discuss baseline measurements, laboratory testing and available treatment options. The consultation does not guarantee eligibility for medication.

No. GLP-1 or related prescription medications are not appropriate for every patient. The provider must consider your health history, current medications, potential contraindications, treatment goals and possible side effects.

Your plan may focus on nutrition, physical activity, behavioral support and medical monitoring, with or without prescription medication.

GLP-1 medications imitate a hormone involved in appetite, digestion and blood-glucose regulation. Certain FDA-approved medications may help eligible patients feel full sooner, reduce appetite and support weight management when combined with nutrition and physical activity.

Not every medication commonly associated with GLP-1 treatment is approved specifically for weight management. Medication selection and availability should be confirmed with the prescribing provider.

No. Semaglutide and tirzepatide are different prescription medications. Semaglutide acts on the GLP-1 receptor, while tirzepatide acts on both GIP and GLP-1 receptors.

Their indications, dosing, contraindications and side-effect considerations differ. A provider should determine whether either option is appropriate; patients should not switch or combine medications on their own.

There is no universal weight-loss timeline. Progress depends on your starting health, treatment plan, medication response, nutrition, activity, sleep, medical conditions and consistency.

Healthy progress is not always linear, and temporary plateaus can occur. No responsible medical weight-loss provider should guarantee a specific number of pounds or a fixed completion date.

Possible side effects depend on the medication. Common gastrointestinal effects associated with certain GLP-1 or GIP/GLP-1 medications can include nausea, vomiting, diarrhea, constipation and abdominal discomfort.

Some symptoms require prompt medical attention. Tell your provider about severe or persistent abdominal pain, repeated vomiting, dehydration, allergic-reaction symptoms or another significant change. Current FDA-approved prescribing information should guide medication-specific counseling. FDA information on tirzepatide for chronic weight management

Laboratory testing may be recommended based on your health history, symptoms, current medications and proposed treatment. Not every patient requires exactly the same tests.

Your provider will explain which evaluations are medically appropriate and whether additional clearance is needed before beginning treatment.

Follow-up frequency depends on the treatment plan, medication, side effects and individual response. Follow-up visits may be used to review progress, appetite, nutrition, activity, measurements, medication tolerance and necessary plan adjustments.

Patients should not change their dose or treatment schedule without instructions from the prescribing provider.

The cost depends on the consultation, recommended follow-ups, laboratory testing, medication and services included in your individualized plan. A generic price may not reflect the total cost for every patient.

Contact Health & MedSpa for current consultation and program information. Ask separately whether medication, laboratory testing or follow-up visits are included.

You can request a consultation through the Health & MedSpa website or call 727-444-0995. During scheduling, ask what information, medication list or previous laboratory records you should bring.

A consultation is the first step toward determining eligibility; it does not guarantee that a particular medication will be prescribed.